Share on StockTwits

Bio Blast Pharma (NASDAQ:ORPN) issued its quarterly earnings data on Friday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.01, American Banking News reports.

Shares of Bio Blast Pharma (NASDAQ:ORPN) opened at 9.79 on Friday. Bio Blast Pharma has a 1-year low of $6.61 and a 1-year high of $11.00. The stock has a 50-day moving average of $7.85 and a 200-day moving average of $7.85. The company’s market cap is $139.3 million.

A number of analysts have recently weighed in on ORPN shares. Analysts at Roth Capital initiated coverage on shares of Bio Blast Pharma in a research note on Monday. They set a “buy” rating and a $15.00 price target on the stock. Analysts at Oppenheimer initiated coverage on shares of Bio Blast Pharma in a research note on Monday. They set an “outperform” rating and a $32.00 price target on the stock.

Receive News & Ratings for Bio Blast Pharma Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio Blast Pharma Ltd and related companies with Analyst Ratings Network's FREE daily email newsletter.